JP2023505215A5 - - Google Patents

Info

Publication number
JP2023505215A5
JP2023505215A5 JP2022533411A JP2022533411A JP2023505215A5 JP 2023505215 A5 JP2023505215 A5 JP 2023505215A5 JP 2022533411 A JP2022533411 A JP 2022533411A JP 2022533411 A JP2022533411 A JP 2022533411A JP 2023505215 A5 JP2023505215 A5 JP 2023505215A5
Authority
JP
Japan
Prior art keywords
copd
pharmaceutical composition
antigen
antibody
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022533411A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023505215A (ja
JP7696900B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/063404 external-priority patent/WO2021113707A1/en
Publication of JP2023505215A publication Critical patent/JP2023505215A/ja
Publication of JP2023505215A5 publication Critical patent/JP2023505215A5/ja
Priority to JP2025096567A priority Critical patent/JP2025164767A/ja
Application granted granted Critical
Publication of JP7696900B2 publication Critical patent/JP7696900B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022533411A 2019-12-06 2020-12-04 Ｉｌ－３３アンタゴニストを投与することによりｃｏｐｄを治療するための方法 Active JP7696900B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025096567A JP2025164767A (ja) 2019-12-06 2025-06-10 Ｉｌ－３３アンタゴニストを投与することによりｃｏｐｄを治療するための方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962944878P 2019-12-06 2019-12-06
US62/944,878 2019-12-06
US202062964966P 2020-01-23 2020-01-23
US62/964,966 2020-01-23
US202063082502P 2020-09-24 2020-09-24
US63/082,502 2020-09-24
PCT/US2020/063404 WO2021113707A1 (en) 2019-12-06 2020-12-04 Methods for treating copd by administering an il-33 antagonist

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025096567A Division JP2025164767A (ja) 2019-12-06 2025-06-10 Ｉｌ－３３アンタゴニストを投与することによりｃｏｐｄを治療するための方法

Publications (3)

Publication Number Publication Date
JP2023505215A JP2023505215A (ja) 2023-02-08
JP2023505215A5 true JP2023505215A5 (enExample) 2023-12-08
JP7696900B2 JP7696900B2 (ja) 2025-06-23

Family

ID=74104197

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022533411A Active JP7696900B2 (ja) 2019-12-06 2020-12-04 Ｉｌ－３３アンタゴニストを投与することによりｃｏｐｄを治療するための方法
JP2025096567A Pending JP2025164767A (ja) 2019-12-06 2025-06-10 Ｉｌ－３３アンタゴニストを投与することによりｃｏｐｄを治療するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025096567A Pending JP2025164767A (ja) 2019-12-06 2025-06-10 Ｉｌ－３３アンタゴニストを投与することによりｃｏｐｄを治療するための方法

Country Status (12)

Country Link
US (1) US20210230265A1 (enExample)
EP (1) EP4069365A1 (enExample)
JP (2) JP7696900B2 (enExample)
KR (1) KR20220110553A (enExample)
CN (1) CN114786775A (enExample)
AU (1) AU2020398168A1 (enExample)
BR (1) BR112022010934A2 (enExample)
CA (1) CA3160521A1 (enExample)
IL (1) IL293544A (enExample)
MX (1) MX2022006812A (enExample)
TW (1) TW202134273A (enExample)
WO (1) WO2021113707A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021258255A1 (en) * 2020-04-22 2022-10-27 The Board Of Regents Of The University Of Texas System Medication return platform for extracting value from unused medications
TW202540173A (zh) * 2024-04-04 2025-10-16 英商梅迪繆思有限公司 治療及選擇對象之方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927044B2 (en) 1998-09-25 2005-08-09 Regeneron Pharmaceuticals, Inc. IL-1 receptor based cytokine traps
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US8178098B2 (en) 2001-04-03 2012-05-15 National Jewish Health Method to inhibit airway hyperresponsiveness using aerosolized T cell receptor antibodies
JP5307708B2 (ja) 2006-06-02 2013-10-02 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒトｉｌ−６受容体に対する高親和性抗体
WO2015057668A1 (en) * 2013-10-15 2015-04-23 Medimmune, Llc Methods for treating chronic obstructive pulmonary disease using benralizumab
TWI784988B (zh) 2016-12-01 2022-12-01 美商再生元醫藥公司 治療發炎症狀的方法

Similar Documents

Publication Publication Date Title
JP2023162343A5 (enExample)
JP2025072593A5 (enExample)
EP3703818B1 (en) Il-4r antagonist for use in a method for treating or preventing asthma
JP2023139071A5 (enExample)
TWI656880B (zh) 投與ｉｌ－４ｒ拮抗劑以治療或預防氣喘之方法
TWI894144B (zh) 藉由投予il-33拮抗劑治療或預防哮喘之方法
JP2022530533A5 (enExample)
KR102337599B1 (ko) 벤랄리주맙을 이용하여 천식 환자에서 강제 호기량을 증가시키는 방법
JP2023508360A (ja) Ｉｌ－３３アンタゴニストおよび／またはｉｌ－４ｒアンタゴニストを投与することによりアレルギー性喘息を治療するまたは予防するための方法
JP2023505215A5 (enExample)
US20240360232A1 (en) Methods for treating chronic obstructive pulmonary disease (copd) by administering an il-4r antagonist
JP2022541191A5 (enExample)
JP2025501239A5 (enExample)
CN114786775A (zh) 通过施用il-33拮抗剂治疗copd的方法
US20250388685A1 (en) Methods for treating chronic rhinosinusitis without nasal polyps by administering an il-4r antagonist
RU2021134810A (ru) Способы лечения или предупреждения астмы посредством введения антагониста il-33
RU2025128783A (ru) Способы лечения хронической обструктивной болезни легких (copd) путем введения антагониста il-4r
TW202544036A (zh) 用抗ｔｓｌｐ抗體治療慢性阻塞性肺病
TW202532439A (zh) 治療氣喘之方法
HK40129473A (en) Methods for increasing forced expiratory volume in asthmatics using benralizumab
JP2020105193A5 (enExample)
RU2023120407A (ru) Способы лечения или предотвращения астмы посредством введения антагониста il-4r
JP2021176886A (ja) Ｉｌ−４ｒアンタゴニストを投与することにより喘息を処置又は予防するための方法
EA050548B1 (ru) Способы лечения или предупреждения аллергической астмы посредством введения антагониста il-33 и/или антагониста il-4r
RU2023107541A (ru) Способы лечения или предупреждения астмы путем введения антагониста il-4r